Status:

COMPLETED

Cell Transplant in Spinal Cord Injury Patients

Lead Sponsor:

Cairo University

Collaborating Sponsors:

Al-Azhar University

Medical Military Academy, Egypt

Conditions:

Chronic Spinal Cord Injury

Eligibility:

All Genders

10-36 years

Phase:

PHASE1

PHASE2

Brief Summary

This study is designed to assess the safety of autologous bone marrow derived cell transplant in chronic spinal cord injury patients. The hypothesis is that the availability of bone marrow derived mes...

Eligibility Criteria

Inclusion

  • Traumatic spinal cord injury
  • No concomitant systemic disease
  • No progress on physiotherapy for at least 6 months
  • Duration of injury from 10 months to 3 years

Exclusion

  • Non-traumatic spinal cord injury whether transverse myelitis or demyelination
  • Concomitant systemic disease
  • Progress can be observed on physiotherapy
  • Acute injury or duration of injury less than 10 months

Key Trial Info

Start Date :

May 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT00816803

Start Date

May 1 2005

End Date

December 1 2008

Last Update

January 5 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cairo University School of Medicine

Cairo, Egypt